Given the significant overexpression of MSLN in mesothelioma, this molecule has emerged as a focal point in mesothelioma research, and its soluble derivative SMRP has been validated as an important biomarker for both diagnosis and prognostic assessment of mesothelioma.76 The gene discussed is MSLN; the disease is mesothelioma.